Minerva Neurosciences, Inc.NERV
Price (close)
$3.45
Market cap
$164.7M
P/E
—
Revenue (TTM)
—
Net income
-$394.3M
Dividend yield
—
1-year total return
59.4%
Net margin
—
Revenue growth
—
Debt / equity
—
What Minerva Neurosciences, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $41.2M | $0 | $0 | $0 | $0 | — |
| Net income | $1.9M | -$49.9M | -$32.1M | -$30.0M | $1.4M | -$293.4M |
| Free cash flow | — | — | -$24.7M | — | — | — |
More on NERV.
- Minerva Neurosciences, Inc. summary
- Minerva Neurosciences, Inc. financial statements
- Minerva Neurosciences, Inc. key metrics
- Minerva Neurosciences, Inc. health scores and style box
- Minerva Neurosciences, Inc. earnings
- Minerva Neurosciences, Inc. dividends
- Minerva Neurosciences, Inc. valuation
- Minerva Neurosciences, Inc. ownership and insiders
- Minerva Neurosciences, Inc. peers
Figures from Minerva Neurosciences, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.